Literature DB >> 23588618

Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: a gene expression study.

Jana Dragojevič1, Janja Zupan, Gregor Haring, Simon Herman, Radko Komadina, Janja Marc.   

Abstract

The role of bone marrow adipocytes in bone tissue is not yet understood. Adipocytes express enzymes for metabolism of free fatty acids and adipokines such as adiponectin, which have been shown to exert different effects on bone cells. Our aim was to find out whether triglyceride (TG) metabolism in bone tissue is associated with osteoblast and osteoclast differentiation by gene expression analysis of lipoprotein lipase (LPL), hormone sensitive lipase (HSL), fatty acid synthase (FASN), adiponectin, RUNX2, RANK, RANKL and OPG. Bone tissue was obtained from patients undergoing hip arthroplasty due to osteoporosis (OP) (50) or osteoarthritis (OA) (48) or from healthy autopsy controls (14). Lower bone mineral density and microstructural parameters were observed in OP compared to OA. The FASN expression did not differ between groups suggesting similar de novo lipogenesis. Lower LPL and HSL in OP suggest lower FFA release and uptake in OP bone tissue. Adiponectin expression was lower in OP than in OA and a trend was seen for controls. These results suggest OP bone has lower TG metabolism than OA and normal bone. In OP bone, lower osteoblastogenesis and higher osteoclast formation were observed and correlation analysis suggests adiponectin, LPL and HSL are associated with higher osteoblastogenesis and lower osteoclastogenesis. This study gives insights into TG metabolism in the human bone microenvironment. We conclude that OP bone tissue exhibits lower osteoblastogenesis, higher osteoclastogenesis and lower TG metabolism compared to OA or healthy controls.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588618     DOI: 10.1007/s00774-013-0445-x

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  32 in total

Review 1.  Adipose tissue as an endocrine organ.

Authors:  R S Ahima; J S Flier
Journal:  Trends Endocrinol Metab       Date:  2000-10       Impact factor: 12.015

2.  Hormone-sensitive lipase-knockout mice maintain high bone density during aging.

Authors:  Wen-Jun Shen; Li-Fen Liu; Shailja Patel; Fredric B Kraemer
Journal:  FASEB J       Date:  2011-05-12       Impact factor: 5.191

3.  Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.

Authors:  Xiang-Hang Luo; Li-Juan Guo; Hui Xie; Ling-Qing Yuan; Xian-Ping Wu; Hou-De Zhou; Er-Yuan Liao
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

4.  Osteoblastogenesis and adipogenesis are higher in osteoarthritic than in osteoporotic bone tissue.

Authors:  Jana Dragojevič; Darja Bitenc Logar; Radko Komadina; Janja Marc
Journal:  Arch Med Res       Date:  2011-08-18       Impact factor: 2.235

5.  Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.

Authors:  Hailan Liu; Jing-Yuan Liu; Xi Wu; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2010-07-18

6.  Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways.

Authors:  Yusuke Shinoda; Masayuki Yamaguchi; Naoshi Ogata; Toru Akune; Naoto Kubota; Toshimasa Yamauchi; Yasuo Terauchi; Takashi Kadowaki; Yasuhiro Takeuchi; Seiji Fukumoto; Toshiyuki Ikeda; Kazuto Hoshi; Ung-il Chung; Kozo Nakamura; Hiroshi Kawaguchi
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

7.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast.

Authors:  Kazuya Oshima; Akihide Nampei; Morihiro Matsuda; Masanori Iwaki; Atsunori Fukuhara; Jun Hashimoto; Hideki Yoshikawa; Iichiro Shimomura
Journal:  Biochem Biophys Res Commun       Date:  2005-06-03       Impact factor: 3.575

8.  Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling.

Authors:  Noboru Yamaguchi; Toshio Kukita; Yin-Ji Li; Noriaki Kamio; Satoshi Fukumoto; Kazuaki Nonaka; Yuzo Ninomiya; Shigemasa Hanazawa; Yoshihisa Yamashita
Journal:  FEBS Lett       Date:  2008-01-15       Impact factor: 4.124

9.  Adiponectin and its receptors are expressed in bone-forming cells.

Authors:  Heidi S Berner; Staale P Lyngstadaas; Axel Spahr; Marta Monjo; Liv Thommesen; Christian A Drevon; Unni Syversen; Janne E Reseland
Journal:  Bone       Date:  2004-10       Impact factor: 4.398

10.  Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro.

Authors:  Alexandre Elbaz; Xiying Wu; Daniel Rivas; Jeffrey M Gimble; Gustavo Duque
Journal:  J Cell Mol Med       Date:  2009-03-27       Impact factor: 5.310

View more
  9 in total

Review 1.  Lipids in the Bone Marrow: An Evolving Perspective.

Authors:  Elizabeth Rendina-Ruedy; Clifford J Rosen
Journal:  Cell Metab       Date:  2019-10-24       Impact factor: 27.287

2.  Fat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis.

Authors:  Kwi Young Kang; In Je Kim; Min A Yoon; Yeon Sik Hong; Sung-Hwan Park; Ji Hyeon Ju
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 3.  Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunology.

Authors:  Bernard J Crespi; Matthew C Go
Journal:  Evol Med Public Health       Date:  2015-09-09

4.  Phenotypic research on senile osteoporosis caused by SIRT6 deficiency.

Authors:  De-Mao Zhang; Di-Xin Cui; Ruo-Shi Xu; Ya-Chuan Zhou; Li-Wei Zheng; Peng Liu; Xue-Dong Zhou
Journal:  Int J Oral Sci       Date:  2016-06-30       Impact factor: 6.344

5.  Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.

Authors:  Sudeshna Goswami; Neelam Sharma-Walia
Journal:  Oncotarget       Date:  2016-09-13

6.  GCTOF-MS Combined LC-QTRAP-MS/MS Reveals Metabolic Difference Between Osteoarthritis and Osteoporotic Osteoarthritis and the Intervention Effect of Erxian Decoction.

Authors:  Zhenyuan Ma; Yibao Wei; Li Zhang; Xiaoqing Shi; Runlin Xing; Taiyang Liao; Nan Yang; Xiaochen Li; Lishi Jie; Peimin Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

7.  Baseline Severity of Sacroiliitis and Extensive Fat Metaplasia Predicts the Progression of Backfill at the Sacroiliac Joint in Patients With Axial Spondyloarthritis.

Authors:  Yimeng Zhang; Zikang Guo; Lisong Wang; Ying Zhan; Jin Qu; Xinwei Lei
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

8.  Epigenetic enzymes influenced by oxidative stress and hypoxia mimetic in osteoblasts are differentially expressed in patients with osteoporosis and osteoarthritis.

Authors:  Peter Vrtačnik; Janja Zupan; Vid Mlakar; Tilen Kranjc; Janja Marc; Barbara Kern; Barbara Ostanek
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

9.  Vitamin D Receptor Gene Variants Susceptible to Osteoporosis in Arab Post-Menopausal Women.

Authors:  Mohammed G A Ansari; Abdul Khader Mohammed; Kaiser A Wani; Syed D Hussain; Abdullah M Alnaami; Saba Abdi; Naji J Aljohani; Nasser M Al-Daghri
Journal:  Curr Issues Mol Biol       Date:  2021-09-27       Impact factor: 2.976

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.